LIVESTRONG and Penn Medicine Announce Partnership to Bring Online Care Plan Tool to Cancer Survivors

AUSTIN, TX and PHILADELPHIA, PA, May 27 (MARKET WIRE)
--
The Lance Armstrong Foundation (LAF) and Penn Medicine announced today a
four-year partnership to further develop and disseminate the LIVESTRONG
Care Plan Powered by Penn Medicine's OncoLink. This free service gives
cancer survivors, their families and physicians the ability to create an
individualized plan of care using up-to-date treatment information based
on Institute of Medicine recommendations, as well as educating them about
their options to maintain optimal health once they are out of treatment.

The LIVESTRONG Care Plan assists adults diagnosed with cancer in
understanding and planning for such issues as: potential late effects of
treatment; recommendations for cancer screening (recurrence or new
primary); psychosocial effects (including relationships and
sexuality/fertility); recommendations for a healthy lifestyle; genetic
counseling (if appropriate); effective prevention options; and a list of
resources made available through the LIVESTRONG cancer survivorship
support services.

"There are currently 12 million cancer survivors in the United States and
28 million worldwide," said Doug Ulman, President and CEO of the Lance
Armstrong Foundation. "The lack of post-cancer medical care leaves a
staggering number of people without support. The LIVESTRONG Care Plan is a
simple, easily accessible resource to help people manage the ongoing
effects of cancer treatments, communicate with their medical team and get
the support they need in all aspects of their fight."

Originally launched as OncoLife(R) on Penn Medicine's OncoLink(R) website
in 2007, the tool is the only one of its kind, created and updated
continuously by a team of cancer physicians and nurses. With its
transition to the LIVESTRONG Care Plan, it will be able to reach tens of
thousands of additional cancer survivors, their friends, families and
health care providers through the LAF's many supportive activities and
programs. Available in Spanish as well as English, the LIVESTRONG Care
Plan is designed to also help facilitate a meaningful discussion between
cancer survivors and their health care providers. For example, the care
plan provides users with a report outlining medical tests survivors should
discuss with their physician once they have completed active treatment.

"The LIVESTRONG Care Plan empowers cancer survivors to take an active role
in their health care by providing customized information based on the
cancer therapies they receive," said James M. Metz, MD., associate
professor at Penn Medicine's Department of Radiation Oncology and
Editor-in-Chief of OncoLink(R). "This unique tool allows them to open
meaningful dialog with their health care team to assist them in their
continued journey through cancer survivorship."

The LAF's interest in providing a state-of-the-art care plan through its
Network reaches back to 2006 and the first meeting of the LIVESTRONG
Survivorship Center of Excellence Network which identified the need for a
care plan through which cancer survivors could document important
milestones in their cancer experiences. The benefit of cancer survivorship
care plans was embraced by an Institute of Medicine report, "From Cancer
Patient to Cancer Survivor: Lost in Transition," in November 2005.

Today's announcement of a partnership between LAF and Penn Medicine
supports the mission of both entities to provide cancer survivors around
the world an easy and accessible way for them to take charge and optimize
the quality of their lives. For more information or to access this new
tool, go to www.LIVESTRONGCarePlan.org.

About The Lance Armstrong Foundation:

At the Lance Armstrong Foundation, we fight for the 28 million people
around the world living with cancer today. There can be -- and should be
-- life after cancer for more people. That's why we kick in at the moment
of diagnosis, giving people the resources and support they need to fight
cancer head-on. We find innovative ways to raise awareness, fund research
and end the stigma about cancer that many survivors face. We connect
people and communities to drive social change, and we call for state,
national and world leaders to help fight this disease. Anyone anywhere
can join our fight against cancer. Join us at www.LIVESTRONG.org.

About PENN Medicine:

PENN Medicine is a $3.6 billion enterprise dedicated to the related
missions of medical education, biomedical research, and excellence in
patient care. PENN Medicine consists of the University of Pennsylvania
School of Medicine (founded in 1765 as the nation's first medical school)
and the University of Pennsylvania Health System.

Penn's School of Medicine is currently ranked #3 in the nation in U.S.News
& World Report's survey of top research-oriented medical schools; and,
according to the National Institutes of Health, received over $366 million
in NIH grants (excluding contracts) in the 2008 fiscal year. Supporting
1,700 fulltime faculty and 700 students, the School of Medicine is
recognized worldwide for its superior education and training of the next
generation of physician-scientists and leaders of academic medicine.

The University of Pennsylvania Health System (UPHS) includes its flagship
hospital, the Hospital of the University of Pennsylvania, rated one of the
nation's top ten "Honor Roll" hospitals by U.S.News & World Report;
Pennsylvania Hospital, the nation's first hospital; and Penn Presbyterian
Medical Center, named one of the nation's "100 Top Hospitals" for
cardiovascular care by Thomson Reuters. In addition UPHS includes a
primary-care provider network; a faculty practice plan; home care,
hospice, and nursing home; three multispecialty satellite facilities; as
well as the Penn Medicine at Rittenhouse campus, which offers
comprehensive inpatient rehabilitation facilities and outpatient services
in multiple specialties.

CONTACT:
Lauren Pfeifle Willis
Edelman
512-634-3655
Email Contact

Holly Auer
Penn Medicine
215-349-5659
Email Contact

Copyright 2009, Market Wire, All rights reserved.

-0-